Genomics of cutaneous melanoma: focus on next-generation sequencing approaches and bioinformatics

Abstract

Cutaneous melanoma is caused by the uncontrolled growth of epidermal melanocytes. Melanoma continues to be a rare form of skin cancer but causes the majority of skin cancer related deaths. For many years the scientific community has focused on the investigation of the pathogenesis leading to melanoma, with the aim of better understanding its complexity and the potential advancement of therapeutic strategies. In this paper, the genomic features characterising the development of cutaneous melanoma are reviewed. Next-generation sequencing technologies and bioinformatics tools are currently state-of-the-art approaches in basic, applied and clinical cancer research. In this review, most of the available tools for revealing the mutational landscape are outlined.

Keywords

Melanoma / bioinformatics / somatic mutations / next-generation sequencing

References

[1] UongA.Melanocytes in development and cancer..J Cell Physiol2010;222:38-41 PMCID:PMC2783760

[2] NikolaouV.Emerging trends in the epidemiology of melanoma..Br J Dermatol2014;170:11-9

[3] GarbeC.Melanoma epidemiology and trends..Clinics in dermatology2009;27:3-9

[4] ECIS- European Cancer Information System. Available from: https://ecis.jrc.ec.europa.eu [Last accessed on 26 Feb 2019]

[5] ForseaAM,De VriesE,GellerA.Melanoma incidence and mortality in Europe: new estimates, persistent disparities..Br J Dermatol2012;167:1124-30

[6] HussussianCJ,GoldsteinAM,AllyDS.Germline p16 mutations in familial melanoma..Nature genetics1994;8:15-21

[7] KambA,EelesR,GruisNA.Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus..Nature genetics1994;8:23-6

[8] de SnooFA.Cutaneous melanoma susceptibility and progression genes..Cancer Lett2005;230:153-86

[9] AoudeLG,PritchardAL.Genetics of familial melanoma: 20 years after CDKN2A..Pigment Cell Melanoma Res2015;28:148-60

[10] AthanasiadisEI,ChatzinasiouF,BourdakouMM.A Web-based database of genetic association studies in cutaneous melanoma enhanced with network-driven data exploration tools..Database (Oxford)2014;2014:bau101 PMCID:PMC4224266

[11] AntonopoulouK,LillCM,KypreouKP.Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database..J Invest Dermatol2015;135:1074-9

[12] ChatzinasiouF,KypreouK,NicolaouV.Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma..J Natl Cancer Inst2011;103:1227-35 PMCID:PMC4719704

[13] LawMH,LeeJE,MartinNG.Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma..Nature genetics2015;47:987-95 PMCID:PMC4557485

[14] PaduaRA,CurrieGA.A novel transforming gene in a human malignant melanoma cell line..Nature1984;311:671-3

[15] DaviesH,CoxC,EdkinsS.Mutations of the BRAF gene in human cancer..Nature2002;417:949-54

[16] PleasanceED,StephensPJ,HumphraySJ.A comprehensive catalogue of somatic mutations from a human cancer genome..Nature2010;463:191-6 PMCID:PMC3145108

[17] HodisE,KryukovGV,ImielinskiM.A landscape of driver mutations in melanoma..Cell2012;150:251-63 PMCID:PMC3600117

[18] KrauthammerM,HaBH,BacchiocchiA.Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma..Nature genetics2012;44:1006-14 PMCID:PMC3432702

[19] The Cancer Genome Atlas [Internet]. Available from: https://cancergenome.nih.gov/. [Last accessed on 24 Feb 2019]

[20] GreenmanC,SmithR,HunterC.Patterns of somatic mutation in human cancer genomes..Nature2007;446:153-8 PMCID:PMC2712719

[21] AlexandrovLB,WedgeDC,BehjatiS.Signatures of mutational processes in human cancer..Nature2013;500:415-21 PMCID:PMC3776390

[22] HaywardNK,WaddellN,FieldMA.Whole-genome landscapes of major melanoma subtypes..Nature2017;545:175-80

[23] Gonzalez-PerezA.Functional impact bias reveals cancer drivers..Nucleic Acids Res2012;40:e169 PMCID:PMC3505979

[24] Gonzalez-PerezA,Deu-PonsJ,SchroederMP.IntOGen-mutations identifies cancer drivers across tumor types..Nature methods2013;10:1081-2 PMCID:PMC5758042

[25] LawrenceMS,PolakP,CibulskisK.Mutational heterogeneity in cancer and the search for new cancer-associated genes..Nature2013;499:214-8 PMCID:PMC3919509

[26] RaphaelBJ,OesperL.Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine..Genome medicine2014;6:5 PMCID:PMC3978567

[27] XuC.A review of somatic single nucleotide variant calling algorithms for next-generation sequencing data..Comput Struct Biotechnol J2018;16:15-24 PMCID:PMC5852328

[28] ZhangJ,SunJ,FoltzG.Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing..Brief Bioinformatics2014;15:244-55

[29] Cosmic. COSMIC - Catalogue of Somatic Mutations in Cancer [Internet]. Available from: https://cancer.sanger.ac.uk/cosmic. [Last accessed on 24 Feb 2019]

[30] ForbesSA,BoutselakisH,BindalN.COSMIC: somatic cancer genetics at high-resolution..Nucleic Acids Res2017;45:D777-83 PMCID:PMC5210583

[31] KassahnKS,NonesK,MillerDK.Somatic point mutation calling in low cellularity tumors..PLoS One2013;8:e74380 PMCID:PMC3826759

[32] RadenbaughAJ,EwingA,CollissonEA.RADIA: RNA and DNA integrated analysis for somatic mutation detection..PLoS One2014;9:e111516 PMCID:PMC4236012

[33] HansenNF,MeiL,MullikinJC.Shimmer: detection of genetic alterations in tumors using next-generation sequence data..Bioinformatics2013;29:1498-503 PMCID:PMC3673219

[34] SOAP : Short Oligonucleotide Analysis Package [Internet]. Available from: http://soap.genomics.org.cn/. [Last accessed on 24 Feb 2019]

[35] LaiZ,AhdesmakiM,HofmannO.VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research..Nucleic Acids Res2016;44:e108 PMCID:PMC4914105

[36] KoboldtDC,LarsonDE,McLellanMD.VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing..Genome Res2012;22:568-76 PMCID:PMC3290792

[37] JonesD,DaviesH,ButlerAP.cgpCaVEManWrapper: Simple Execution of CaVEMan in Order to Detect Somatic Single Nucleotide Variants in NGS Data..Curr Protoc Bioinformatics2016;56:15.10.1-15.10.18 PMCID:PMC6097605

[38] WangW,XuF,WongMP.FaSD-somatic: a fast and accurate somatic SNV detection algorithm for cancer genome sequencing data..Bioinformatics2014;30:2498-500

[39] RothA,MorinR,HaG.JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data..Bioinformatics2012;28:907-13 PMCID:PMC3315723

[40] LiH.A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data..Bioinformatics.2011;27:2987-93 PMCID:PMC3198575

[41] ChristoforidesA,WeissGJ,Von HoffDD.Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs..BMC Genomics2013;14:302 PMCID:PMC3751438

[42] LiuY,AluruS.SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations..BMC Syst Biol2016;10:47 PMCID:PMC4977481

[43] LarsonDE,ChenK,AbbottTE.SomaticSniper: identification of somatic point mutations in whole genome sequencing data..Bioinformatics2012;28:311-7 PMCID:PMC3268238

[44] KimS,BhutaniK,PatelA.Virmid: accurate detection of somatic mutations with sample impurity inference..Genome Biol2013;14:R90 PMCID:PMC4054681

[45] GerstungM,RechsteinerM,SchramlP.Reliable detection of subclonal single-nucleotide variants in tumour cell populations..Nat Commun2012;3:811

[46] ShiraishiY,ChibaK,NagataY.An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data..Nucleic Acids Res2013;41:e89 PMCID:PMC3627598

[47] WilmA,BertrandD,OngSH.LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets..Nucleic Acids Res2012;40:11189-201 PMCID:PMC3526318

[48] Carrot-ZhangJ.LoLoPicker: detecting low allelic-fraction variants from low-quality cancer samples..Oncotarget2017;8:37032-40 PMCID:PMC5514890

[49] CibulskisK,CarterSL,JaffeD.Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples..Nat Biotechnol2013;31:213-9 PMCID:PMC3833702

[50] SaundersCT,SwamyS,MurrayLJ.Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs..Bioinformatics2012;28:1811-7

[51] GarrisonE.Haplotype-based variant detection from short-read sequencing..Quantitative Biology2012;

[52] UsuyamaN,SatoY,HommaY.HapMuC: somatic mutation calling using heterozygous germ line variants near candidate mutations..Bioinformatics2014;30:3302-9 PMCID:PMC4816033

[53] SenguptaS,ZhuY,NaughtonK.Ultra-fast local-haplotype variant calling using paired-end DNA-sequencing data reveals somatic mosaicism in tumor and normal blood samples..Nucleic Acids Res2016;44:e25 PMCID:PMC4756850

[54] RimmerA,MathiesonI,TwiggSRF.Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications..Nat Genet2014;46:912-8 PMCID:PMC4753679

[55] CantarelBL,McNeillN,MackeyAJ.BAYSIC: a Bayesian method for combining sets of genome variants with improved specificity and sensitivity..BMC Bioinformatics2014;15:104 PMCID:PMC3999887

[56] DingJ,RothA,TseK.Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data..Bioinformatics2012;28:167-75 PMCID:PMC3259434

[57] SpinellaJF,VidalR,CassartP.SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing..BMC Genomics2016;17:912 PMCID:PMC5109690

[58] FangLT,ChhibberA,FanY.An ensemble approach to accurately detect somatic mutations using SomaticSeq..Genome Biol2015;16:197 PMCID:PMC4574535

[59] HsuYC,KaoTY,ShiehGS.Detection of somatic mutations in exome sequencing of tumor-only samples..Sci Rep2017;7:15959 PMCID:PMC5698426

[60] KalatskayaI,SpearsM,BartlettJMS.ISOWN: accurate somatic mutation identification in the absence of normal tissue controls..Genome Med2017;9:59 PMCID:PMC5490163

[61] MullerE,BraultB,PaimparayG.OutLyzer: software for extracting low-allele-frequency tumor mutations from sequencing background noise in clinical practice..Oncotarget2016;7:79485-93 PMCID:PMC5346729

[62] DunnT,Emig-AgiusD,LeiS.Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data..Bioinformatics2018;

[63] KockanC,SarrafiI,McConeghyB.SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA..Bioinformatics2017;33:26-34

[64] SmithKS,PeiS,JordanCT.SomVarIUS: somatic variant identification from unpaired tissue samples..Bioinformatics2016;32:808-13

[65] YangL,GehlenborgN,HaseleyPS.Diverse mechanisms of somatic structural variations in human cancer genomes..Cell2013;153:919-29 PMCID:PMC3704973

[66] XiR,HadjipanayisA,ParkPJ.BIC-seq: a fast algorithm for detection of copy number alterations based on high-throughput sequencing data..Genome Biol2010;11:O10 PMCID: PMC3026225

[67] ChenK,McLellanMD,KalickiJM.BreakDancer: an algorithm for high resolution mapping of genomic structural variation..Nat Methods2009;6:677-81 PMCID:PMC3661775

[68] DrierY,CarterSL,GabrielSB.Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability..Genome Res2013;23:228-35 PMCID:PMC3561864

[69] TalevichE,BottonT.CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing..PLoS computational biology2016;12:e1004873 PMCID:PMC4839673

[70] KrummN,KoA,MaligM.Copy number variation detection and genotyping from exome sequence data..Genome Res2012;22:1525-32 PMCID:PMC3409265

[71] RauschT,SchlattlA,BenesV.DELLY: structural variant discovery by integrated paired-end and split-read analysis..Bioinformatics2012;28:i333-9 PMCID:PMC3436805

[72] MalhotraA,FaustGG,ClarkRA.Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms..Genome Res2013;23:762-76 PMCID:PMC3638133

[73] SindiS,BashirA.A geometric approach for classification and comparison of structural variants..Bioinformatics2009;25:i222-30 PMCID:PMC2687962

[74] SindiSS,PengLC,RaphaelBJ.An integrative probabilistic model for identification of structural variation in sequencing data..Genome Biol2012;13:R22 PMCID:PMC3439973

[75] EscaramísG,BassaganyasL,TubioJMC.PeSV-Fisher: identification of somatic and non-somatic structural variants using next generation sequencing data..PLoS One2013;8:e63377 PMCID:PMC3660373

[76] HormozdiariF,McPhersonA,SahinalpSC.Simultaneous structural variation discovery among multiple paired-end sequenced genomes..Genome Res2011;21:2203-12 PMCID:PMC3227108

[77] TangX,ShameerK,WillsQ.The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data..Nucleic Acids Res2014;42:e172 PMCID:PMC4267611

[78] PiskolR,LiJB.Reliable identification of genomic variants from RNA-seq data..Am J Hum Genet2013;93:641-51 PMCID:PMC3791257

[79] StrattonMR,FutrealPA.The cancer genome..Nature2009;458:719-24 PMCID:PMC2821689

[80] KontogianniG,MaglogiannisI,PapadodimaO.Dissecting the mutational landscape of cutaneous melanoma: an omic analysis based on patients from Greece..Cancers2018;10:96 PMCID:PMC5923351

[81] KaminkerJS,WatanabeC.CanPredict: a computational tool for predicting cancer-associated missense mutations..Nucleic Acids Res2007;35:W595-8 PMCID:PMC1933186

[82] González-PérezA.Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel..Am J Hum Genet2011;88:440-9 PMCID:PMC3071923

[83] ShihabHA,CooperDN,BarkerGL.Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models..Human mutation2013;34:57-65 PMCID:PMC3558800

[84] DavydovEV,SirotaM,SidowA.Identifying a high fraction of the human genome to be under selective constraint using GERP++..PLoS Comput Biol2010;6:e1001025 PMCID:PMC2996323

[85] KaminkerJS,WaughA,PetersB.Distinguishing cancer-associated missense mutations from common polymorphisms..Cancer Res2007;67:465-73

[86] RevaB,SanderC.Predicting the functional impact of protein mutations: application to cancer genomics..Nucleic Acids Res2011;39:e118 PMCID:PMC3177186

[87] RevaB,SanderC.Determinants of protein function revealed by combinatorial entropy optimization..Genome Biol2007;8:R232 PMCID:PMC2258190

[88] SchwarzJM,SchuelkeM.MutationTaster2: mutation prediction for the deep-sequencing age..Nat Methods2014;11:361-2

[89] Gonzalez-PerezA.Functional impact bias reveals cancer drivers..Nucleic Acids Res2012;40:e169 PMCID:PMC3505979

[90] Ferrer-CostaC,ZamakolaL,de la CruzX.PMUT: a web-based tool for the annotation of pathological mutations on proteins..Bioinformatics2005;21:3176-8

[91] AdzhubeiIA,PeshkinL,GerasimovaA.A method and server for predicting damaging missense mutations.2010;United StatesNat Methods248-9

[92] ChoiY,MurphyS,ChanAP.Predicting the functional effect of amino acid substitutions and indels..PLoS One2012;7:e46688 PMCID:PMC3466303

[93] NgPC.Predicting deleterious amino acid substitutions..Genome Res2001;11:863-74 PMCID:PMC311071

[94] YueP,MoultJ.SNPs3D: candidate gene and SNP selection for association studies..BMC Bioinformatics2006;7:166 PMCID:PMC1435944

[95] Gonzalez-PerezA,Lopez-BigasN.Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation..Genome Med2012;4:89 PMCID:PMC4064314

[96] HuaX,YangY,LiuP.DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies..Am J Hum Genet2013;93:439-51 PMCID:PMC3769934

[97] DeesND,KandothC,SchierdingW.MuSiC: identifying mutational significance in cancer genomes..Genome Res2012;22:1589-98 PMCID:PMC3409272

[98] YounA.Identifying cancer driver genes in tumor genome sequencing studies..Bioinformatics2011;27:175-81 PMCID:PMC3018819

[99] CarterH,IsikL,VelculescuVE.Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations..Cancer Res2009;69:6660-7 PMCID:PMC2763410

[100] WongWC,CarterH,RyanMC.CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer..Bioinformatics2011;27:2147-8 PMCID:PMC3137226

[101] TanH,ZhouX.A novel missense-mutation-related feature extraction scheme for “driver” mutation identification..Bioinformatics.2012;28:2948-55 PMCID:PMC3496432

[102] van DykE,WesselsLFA.A scale-space method for detecting recurrent DNA copy number changes with analytical false discovery rate control..Nucleic Acids Res2013;41:e100 PMCID:PMC3643574

[103] ZhangQ,LarsonDE,McLellanMD.CMDS: a population-based method for identifying recurrent DNA copy number aberrations in cancer from high-resolution data..Bioinformatics2010;26:464-9 PMCID:PMC2852218

[104] MermelCH,HillB,BeroukhimR.GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers..Genome Biol2011;12:R41 PMCID:PMC3218867

[105] Sanchez-GarciaF,MozesE.JISTIC: Identification of significant targets in cancer..BMC Bioinformatics2010;11:189 PMCID:PMC2873534

[106] RyslikGA,CheungKH,ZhaoH.Utilizing protein structure to identify non-random somatic mutations..BMC Bioinformatics2013;14:190 PMCID:PMC3691676

[107] YeJ,LunneyEA,TengCH.Statistical method on nonrandom clustering with application to somatic mutations in cancer..BMC Bioinformatics2010;11:11 PMCID:PMC2822753

[108] KoutsandreasT,PilalisE,PapadodimaO.Analyzing and visualizing genomic complexity for the derivation of the emergent molecular networks..IJMSTR2016;4:30-49

[109] VandinF,RaphaelBJ.Algorithms for detecting significantly mutated pathways in cancer..J Comput Biol2011;18:507-22

[110] SubramanianA,MoothaVK,EbertBL.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles..Proc Natl Acad Sci U S A2005;102:15545-50 PMCID:PMC1239896

[111] CirielloG,SanderC.Mutual exclusivity analysis identifies oncogenic network modules..Genome Res2012;22:398-406 PMCID:PMC3266046

[112] LeisersonMDM,SharanR.Simultaneous identification of multiple driver pathways in cancer..PLoS Comput Biol2013;9:e1003054 PMCID:PMC3662702

[113] CeramiE,SchultzN,SanderC.Automated network analysis identifies core pathways in glioblastoma..PLoS One2010;5:e8918 PMCID:PMC2820542

[114] WendlMC,LinL,MardisER.PathScan: a tool for discerning mutational significance in groups of putative cancer genes..Bioinformatics2011;27:1595-602 PMCID:PMC3106187

[115] BocaSM,VelculescuVE,ParmigianiG.Patient-oriented gene set analysis for cancer mutation data..Genome Biol2010;11:R112 PMCID:PMC3156951

[116] MillerCA,SulmanEP,MilosavljevicA.Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors..BMC Med Genomics2011;4:34 PMCID:PMC3102606

[117] MaldonadoJL,PatelH,BusamK.Determinants of BRAF mutations in primary melanomas..J Natl Cancer Inst2003;95:1878-90

[118] BastianBC.The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia..Annu Rev Pathol2014;9:239-71 PMCID:PMC4831647

[119] SimanshuDK,McCormickF.RAS proteins and their regulators in human disease..Cell2017;170:17-33 PMCID:PMC5555610

[120] CoxAD.Ras history: the saga continues..Small GTPases2010;1:2-27 PMCID:PMC3109476

[121] FedorenkoIV,SmalleyKSM.NRAS mutant melanoma: biological behavior and future strategies for therapeutic management..Oncogene2013;32:3009-18 PMCID:PMC3978385

[122] VigilD,RossmanKL.Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?.Nat Rev Cancer2010;10:842-57 PMCID:PMC3124093

[123] Genomic Classification of Cutaneous Melanoma..Cell2015;161:1681-96 PMCID:PMC4580370

[124] CirenajwisH,EkedahlH,KvistA.NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics..Mol Oncol2017;11:438-51 PMCID:PMC5527484

[125] HuangFW,XuMJ,ChinL.Highly recurrent TERT promoter mutations in human melanoma..Science2013;339:957-9 PMCID:PMC4423787

[126] HornS,RachakondaPS,SuckerA.TERT promoter mutations in familial and sporadic melanoma..Science2013;339:959-61

[127] ShainAH,YuR,LiuS.Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution..Cancer Cell2018;34:45-55.e4 PMCID:PMC6319271

[128] ZhaoR,LeeMH,DongZ.Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer..EBioMedicine2016;8:30-9 PMCID:PMC4919535

[129] PalmieriG,CasulaM,MandalàM.Molecular pathways in melanomagenesis: what we learned from next-generation sequencing approaches..Curr Oncol Rep2018;20:86 PMCID:PMC6153571

[130] BaileyMH,Porta-PardoE,BertrandD.Comprehensive characterization of cancer driver genes and mutations..Cell2018;173:371-85.e18 PMCID:PMC6029450

[131] Ortega-MolinaA.PTEN in cancer, metabolism, and aging..Trends Endocrinol Metab2013;24:184-9 PMCID:PMC3836169

[132] HelgadottirH,GirnitaA.Personalized medicine in malignant melanoma: towards patient tailored treatment..Front Oncol2018;8:202 PMCID:PMC6006716

[133] MortRL,PattonEE.The melanocyte lineage in development and disease..Development2015;142:620-32 PMCID:PMC4325379

[134] MehrotraA,ArasS,de la SernaIL.SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma..Crit Rev Eukaryot Gene Expr2014;24:151-61 PMCID:PMC4104388